Key Findings
Legalization of cannabis for medical purposes has given a huge boost to the cannabis testing market. By the end of the forecast period of 2018-2026, the Europe cannabis testing market is predicted to exhibit a CAGR of 10.50%.

Market Insights
The market segments include cannabis testing by testing methods ( eg: potency cannabis testing, terpene profiling cannabis testing, residual solvent screening cannabis testing, heavy metal cannabis testing, genetic cannabis testing, and microbial analysis cannabis testing), by end-users ( laboratories, research industries), by product and software segments and by Cannabis type( topical, solid edible, liquid edible and inhaling cannabis). Although the market looks promising, a lack of uniform industry standards and high costs related to laboratory analytical instruments used for cannabis testing are presenting major challenges to the market growth. The UK market presently dominates this region. Other geographies profiled in this report include Germany, France and the rest of Europe.

Competitive Insights
Some of the prominent market players include Agilent Technologies Inc, Sigma-Aldrich, Digipath Inc, Millipore Sigma, Perkinelmer Inc, Steep Hill Halent Laboratories Inc, CMT Laboratories Inc, Eli Lilly, Waters Corporation, Thermo Fisher Scientific Inc, Lablynx, Inc, and AB Sciex LLC.